| BioVision |
4388-1000 |
SDF-1alpha (CXCL12), murine recombinant
|
1 mg |
|
|
| BioVision |
4388-50 |
SDF-1alpha (CXCL12), murine recombinant
|
50 μg |
|
|
| BioVision |
4389-10 |
SDF-1beta/CXCL12, feline recombinant
|
10 μg |
|
|
| BioVision |
4370-20 |
4-1BB Receptor, human recombinant
|
20 μg |
|
|
| BioVision |
4371-10 |
PPARɣ, Human, Recombinant
|
10 µg |
|
|
| BioVision |
4372-1000 |
BD-2, human recombinant
|
1 mg |
|
|
| BioVision |
4372-20 |
BD-2, human recombinant
|
20 μg |
|
|
| BioVision |
4375-10 |
Lymphotactin, human recombinant
|
10 μg |
|
|
| BioVision |
4375-1000 |
Lymphotactin, human recombinant
|
1 mg |
|
|
| BioVision |
4376-100 |
IL-27b / EBI-3, human recombinant
|
100 μg |
|
|
| BioVision |
4376-1000 |
IL-27b / EBI-3, human recombinant
|
1 mg |
|
|
| BioVision |
4376-20 |
IL-27b / EBI-3, human recombinant
|
20 μg |
|
|
| BioVision |
4377-100 |
IL-27 / EBI-3, murine recombinant
|
100 μg |
|
|
| BioVision |
4368-5 |
Leptin, rat recombinant
|
5 mg |
|
|
| BioVision |
4369-100 |
4-1BBL, human recombinant
|
100 μg |
|
|
| BioVision |
4369-1000 |
4-1BBL, human recombinant
|
1 mg |
|
|
| BioVision |
4369-20 |
4-1BBL, human recombinant
|
20 μg |
|
|
| BioVision |
4370-100 |
4-1BBR, human recombinant
|
100 μg |
|
|
| BioVision |
4370-1000 |
4-1BBR, human recombinant
|
1 mg |
|
|
| BioVision |
4365-1000 |
VEGF165, rat recombinant
|
1 mg |
|
|
| BioVision |
4365-50 |
VEGF165, rat recombinant
|
50 μg |
|
|
| BioVision |
4366-02 |
Leptin, human recombinant
|
200 μg |
|
|
| BioVision |
4366-1 |
Leptin, human recombinant
|
1 mg |
|
|
| BioVision |
4366-5 |
Leptin, human recombinant
|
5 mg |
|
|
| BioVision |
4366-10 |
Leptin, human recombinant
|
10 mg |
|
|
| BioVision |
4367-02 |
Leptin, murine recombinant
|
200 μg |
|
|
| BioVision |
4367-1 |
Leptin, murine recombinant
|
1 mg |
|
|
| BioVision |
4367-5 |
Leptin, murine recombinant
|
5 mg |
|
|
| BioVision |
4368-02 |
Leptin, rat recombinant
|
200 μg |
|
|
| BioVision |
4368-1 |
Leptin, rat recombinant
|
1 mg |
|
|
| BioVision |
4352-1000 |
TPO, murine recombinant
|
1 mg |
|
|
| BioVision |
4352-50 |
TPO, murine recombinant
|
50 μg |
|
|
| BioVision |
4353-1000 |
CXCL16, mouse recombinant
|
1 mg |
|
|
| BioVision |
4353-25 |
CXCL16, mouse recombinant
|
25 μg |
|
|
| BioVision |
4354-10 |
TRAIL/Apo2L, human recombinant
|
10 μg |
|
|
| BioVision |
4354-1000 |
TRAIL/Apo2L, human recombinant
|
1 mg |
|
|
| BioVision |
4354-50 |
TRAIL/Apo2L, human recombinant
|
50 μg |
|
|
| BioVision |
4355-1000 |
ENA 78, mouse recombinant
|
1 mg |
|
|
| BioVision |
4355-20 |
ENA 78, mouse recombinant
|
20 μg |
|
|
| BioVision |
4356-1000 |
PF 4, human platelets
|
1 mg |
|
|
| BioVision |
4356-20 |
PF 4, human platelets
|
20 μg |
|
|
| BioVision |
4360-10 |
TWEAK, human recombinant
|
10 μg |
|
|
| BioVision |
4360-1000 |
TWEAK, human recombinant
|
1 mg |
|
|
| BioVision |
4363-10 |
VEGF165, human recombinant
|
10 μg |
|
|
| BioVision |
4363-1000 |
VEGF165, human recombinant
|
1 mg |
|
|
| BioVision |
4363-50 |
VEGF165, human recombinant
|
50 μg |
|
|
| BioVision |
4364-10 |
VEGF165, murine recombinant
|
10 μg |
|
|
| BioVision |
4364-1000 |
VEGF165, murine recombinant
|
1 mg |
|
|
| BioVision |
4364-50 |
VEGF165, murine recombinant
|
50 μg |
|
|
| BioVision |
4365-10 |
VEGF165, rat recombinant
|
10 μg |
|
|